NCT04707313-1

Weight loss is harder for some people than it is for others.  For people who have not met weight loss goals through dieting, our clinical study may be an option.

Obesity is a serious health condition characterized by excess weight or body fat that may affect an individual’s health and, in some cases, can affect people both physically and psychologically.  See if you may qualify for a clinical trial of an oral study drug for weight loss.

Card Summary Component

Who may participate

 

This study may be an option for you if you:

  • Are between 18 to 75 years of age
  • Are thinking about losing weight
  • Have a body mass index (BMI) of 30 or higher
  • Do not have type 1 or type 2 diabetes
  • Have not participated in a formal weight loss program in the past 3 months
Condition

Obesity

The disease, disorder, syndrome, illness, or injury that is being studied.

Age

18-75 years

The age a person must be to participate in a clinical trial.

Sex

Male or Female

The sex of people who may participate in a clinical trial. Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

Get started — See if you may qualify

A first step as you consider this study is to answer a 5-minute questionnaire about your health and medical history. If your answers show the study might be a good fit for you, you maychoose to be referred to a study clinic that you select.

You will then be asked to provide your contact information for a study representative to contact you and discuss the next steps. If you’re interested, they will do a more detailed review of your medical history to see if you are able to participate. Only the study staff can determine if you meet the study’s eligibility criteria and are able to enroll in the study.

Your answers to these initial questions will only be linked to you if your responses indicate that you may be eligible to participate in this study and you choose to share your contact information with the study team. Pfizer study team members and our partners will have access to reports containing aggregated data that will not be directly linked back to you. 

Card Summary Component

What to expect

 

If you qualify and decide to participate, you will receive:

  • All clinical trial-related care, study drug, diet and exercise counseling at no charge
  • Close monitoring, by a study doctor, of your health
  • The opportunity to help advance scientific knowledge and potentially improve the care of people with obesity

Your safety while participating is our highest priority. If you have questions or concerns, a study team member is available.

Length of study treatment

34 weeks

Length of study treatment is the length of time the study participants will receive the study treatment.

Number of study visits

About 12 study clinic visits and 9 telephone visits

Each clinical trial’s design specifies the number of study visits and the total length of the trial.

Long-term follow up

4 weeks

Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.

Frequently asked questions

Is there any reimbursement?

Reimbursement for any reasonable expenses that you may have as a result of taking part in the study such as parking, meals, or other travel-related expenses

Is this page helpful?
0
0

Can a participant leave a clinical trial after it has begun?

Your participation is voluntary, and you are free to withdraw at any time. Your privacy will be maintained throughout the study.

Is this page helpful?
0
0